findmyKOL
Clinical trialNCT07250724RecruitingObservational

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

SponsorBactolife A/SEnrollment60Clostridioides Difficile Infection Recurrence
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "Contacts and Locations". The goal of this study is to map the risk of having a C. Difficile infection recurrence (rCDI) after being treated with standard-of-care antibiotics for a C. Difficile infection. The main questions it aims to answer are: * What is the recurrence rate of CDI in the 8 weeks following antibiotic treatment for a first recurrence of CDI? * Does toxin levels of Toxin A and/or B from C. Diff. at baseline predict CDI recurrence risk? Participants will: * Undergo standard of care Antibiotic treatment for first recurrence of CDI * Visit their clinic at 4 different visits over a time period of approximately 9 weeks. (Visits can also be performed remote/via phone call.)

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Emory University Hospital

    Atlanta, Georgia, United States

    Colleen S Kraft, MD, MScNirja Mehta, MD
    Recruiting
  • Corewell Health William Beaumont University Hospital

    Royal Oak, Michigan, United States

    Matthew Sims, Dr.
    Recruiting
  • Mayo Clinic, Minnesota

    Rochester, Minnesota, United States

    Darrell s Pardi, Dr.Sahil Khanna, Dr.
    Recruiting
  • University of Wisconsin-Madison

    Madison, Wisconsin, United States

    Nasia Safdar, MD, PhD, Prof.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2026
Primary completion
15 Oct 2026
Completion
15 Oct 2026
Last update posted
15 Jun 2026
Registered enrollment
60
Registry id
NCT07250724

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.